Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Role of Intra-articular Injections of Platelet-rich Plasma (PRP) in Patients With Rheumatoid Arthritis and Its Impact on Disease Activity and Quality of Life.

NCT04264494 is registered in ClinicalTrials.gov with Dalia Salah Saif as lead sponsor.

NCT NCT04264494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04264494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Role of Intra-articular Injections of Platelet-rich Plasma (PRP) in Patients With Rheumatoid Arthritis and Its Impact on Disease Activity and Quality of Life.
Lead sponsor
Dalia Salah Saif
Phase
Not applicable
Overall status
Unknown status
Start date
February 26, 2018
Completion date
February 26, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ra - rheumatoid arthritis